Nature Reviews Drug Discovery
Volume 19 Issue 6, June 2020
Comment | 11 November 2019
Cloud-based data systems in drug regulation: an industry perspective
Cloud-based systems for data submitted by sponsors to drug regulatory agencies have the potential to accelerate drug development, streamline regulatory review and enhance regulatory decision-making. Here, we provide a vision for integrating cloud-enabled practices in drug regulation globally.
Andrew S. Robertson, Hilary Malone[…] & Max Wegner